Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Biothera -Company Report' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Biothera.-Therapeutic Competitors Report | Mar 2011 | £220 | 100% |
| Biothera-Deals & Alliances Report | Mar 2011 | £380 | 99% |
| Biothera – Product Pipeline Review H2 2011 |
Oct 2011 | £315 | 98% |
| Chronic Lymphocytic Leukemia (CLL) - Pipeline Review H2 2011 |
Oct 2011 | £315 | 62% |
| Melanoma - Pipeline Review H2 2011 |
Sep 2011 | £315 | 61% |
| Colorectal Cancer - Pipeline Review H2 2011 |
Sep 2011 | £315 | 61% |
| Melanoma - Pipeline Review Q1 2011 |
Feb 2011 | £315 | 60% |
| Non-Small Cell Lung Cancer - Pipeline Review H2 2011 |
Sep 2011 | £315 | 58% |
| Nutraceutical Ingredients Innovation Strategies of Makers,Growth Opportunities and U.S. Outlook |
Aug 2007 | £1,450 | 46% |
| Leukemias - Pipeline Review Q3 2011 |
Jul 2011 | £315 | 45% |
| European Market for Nutritional Solutions in Immune and Antihypertensive Health | Mar 2011 | £4,300 | 38% |
- Results 1 - 11 of 11
-
-
- 1
-
-
